The P2 promoter of the IGF1 gene is a major epigenetic locus for GH responsiveness

Pharmacogenomics Journal

Volumn 16, Issue 1, 2016, Pages 102-106

  Ouni, M ^a   Belot, M P ^a   Castell, A L ^b   Fradin, D ^a   Bougneres P ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C; HUMAN GROWTH HORMONE; IGF1 PROTEIN, HUMAN; RECOMBINANT PROTEIN;

ARTICLE; CHILD; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; FEMALE; GENE CLUSTER; GENETIC VARIABILITY; GROWTH RATE; HUMAN; HUMAN CELL; IDIOPATHIC SHORT STATURE; IGF1 GENE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROMOTER REGION; SHORT STATURE; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; BLOOD CELL; CPG ISLAND; DWARFISM; GENE LOCUS; GENETIC EPIGENESIS; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PATHOPHYSIOLOGY;

BLOOD CELLS; CHILD; CPG ISLANDS; DNA METHYLATION; DWARFISM; EPIGENESIS, GENETIC; FEMALE; GENETIC LOCI; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; PROMOTER REGIONS, GENETIC; RECOMBINANT PROTEINS; TRANSCRIPTION, GENETIC;

EID: 84956747770     PISSN: 1470269X     EISSN: 14731150     Source Type: Journal    
DOI: 10.1038/tpj.2015.26     Document Type: Article

References (36)

1. Rosenfeld RG, Bakker B. Compliance and persistence in pediatric and adult patients receiving growth hormone therapy. Endocr Pract 2008; 14: 143-154.
2. Dos Santos C, Essioux L, Teinturier C, Tauber M, Goffin V, Bougnères P et al. A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nat Genet 2004; 36: 720-724.
3. Cohen P, Germak J, Rogol AD, Weng W, Kappelgaard AM, Rosenfeld RG et al. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children. J Clin Endocrinol Metab 2010; 95: 2089-2098.
4. Rosenfeld RG. The pharmacogenomics of human growth. J Clin Endocrinol Metab 2006; 91: 795-796.
5. Toyoshima MTK, Castroneves LA, Costalonga EF, Mendonca BB, Arnhold IJ, Jorge AA et al. Exon 3-deleted genotype of growth hormone receptor (GHRd3) positively influences IGF-1 increase at generation test in children with idiopathic short stature. Clin Endocrinol (Oxf) 2007; 67: 500-504.
6. Ivanov M, Kacevska M, Ingelman-Sundberg M. Epigenomics and interindividual differences in drug response. Clin Pharmacol Ther 2012; 92: 727-736.
7. Weber M, Hellmann I, Stadler MB, Ramos L, Pääbo S, Rebhan M et al. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet 2007; 39: 457-466.
8. Woods KA, Camacho-Hübner C, Savage MO, Clark AJ. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 1996; 335: 1363-1367.
9. Lupu F, Terwilliger JD, Lee K, Segre GV, Efstratiadis A. Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol 2001; 229: 141-162.
10. Lettre G, Butler JL, Ardlie KG, Hirschhorn JN. Common genetic variation in eight genes of the GH/IGF1 axis does not contribute to adult height variation. Hum Genet 2007; 122: 129-139.
11. Okada Y, Kamatani Y, Takahashi A, Matsuda K, Hosono N, Ohmiya H et al. A genome-wide association study in 19 633 Japanese subjects identified LHX3-QSOX2 and IGF1 as adult height loci. Hum Mol Genet 2010; 19: 2303-2312.
12. Kao PC, Matheny AP, Lang CA. Insulin-like growth factor-I comparisons in healthy twin children. J Clin Endocrinol Metab 1994; 78: 310-312.
13. Palles C, Johnson N, Coupland B, Taylor C, Carvajal J, Holly J et al. Identification of genetic variants that influence circulating IGF1 levels: a targeted search strategy. Hum Mol Genet 2008; 17: 1457-1464.
14. Rotwein P. Mapping the growth hormone - Stat5b - IGF-I transcriptional circuit. Trends Endocrinol Metab 2012; 23: 186-193.
15. Bock C, Walter J, Paulsen M, Lengauer T. Inter-individual variation of DNA methylation and its implications for large-scale epigenome mapping. Nucleic Acids Res 2008; 36: e55.
16. Bichell DP, Kikuchi K, Rotwein P. Growth hormone rapidly activates insulin-like growth factor I gene transcription in vivo. Mol Endocrinol 1992; 6: 1899-1908.
17. Chia DJ, Young JJ, Mertens AR, Rotwein P. Distinct alterations in chromatin organization of the two IGF-I promoters precede growth hormone-induced activation of IGF-I gene transcription. Mol Endocrinol 2010; 24: 779-789.
18. Heim MH. The Jak-Stat pathway: cytokine signalling from the receptor to the nucleus. J Recept Signal Transduct 1999; 19: 75-120.
19. Wang Y, Price SE, Jiang H. Cloning and characterization of the bovine class 1 and class 2 insulin-like growth factor-I mRNAs. Domest Anim Endocrinol 2003; 25: 315-328.
20. Yang H, Adamo ML, Koval AP, McGuinness MC, Ben-Hur H, Yang Y et al. Alternative leader sequences in insulin-like growth factor I mRNAs modulate translational efficiency and encode multiple signal peptides. Mol Endocrinol Baltim Md 1995; 9: 1380-1395.
21. Adamo ML, Ben-Hur H, Roberts CT, LeRoith D. Regulation of start site usage in the leader exons of the rat insulin-like growth factor-I gene by development, fasting, and diabetes. Mol Endocrinol 1991; 5: 1677-1686.
22. Alberti C, Chevenne D, Mercat I, Josserand E, Armoogum-Boizeau P, Tichet J et al. Serum concentrations of insulin-like growth factor (IGF)-1 and IGF binding protein-3 (IGFBP-3), IGF-1/IGFBP-3 ratio, and markers of bone turnover: reference values for French children and adolescents and z-score comparability with other references. Clin Chem 2011; 57: 1424-1435.
23. Jansen E, Steenbergh PH, LeRoith D, Roberts CT, Sussenbach JS. Identification of multiple transcription start sites in the human insulin-like growth factor-I gene. Mol Cell Endocrinol 1991; 78: 115-125.
24. Tost J, Gut IG. DNA methylation analysis by pyrosequencing. Nat Protoc 2007; 2: 2265-2275.
25. Liu JL, Yakar S, LeRoith D. Conditional knockout of mouse insulin-like growth factor-1 gene using the Cre/loxP system. Proc Soc Exp Biol Med 2000; 223: 344-351.
26. Kriström B, Lundberg E, Jonsson B, Albertsson-Wikland K. & study group. IGF-1 and growth response to adult height in a randomized GH treatment trial in short non-GH-deficient children. J Clin Endocrinol Metab 2014; 99: 2917-2924.
27. Yakar S, Pennisi P, Wu Y, Zhao H, LeRoith D in Endocrine Development, (eds) Cianfarani S, Clemmons DR, & Savage MO 11-16. KARGER: S Karger AG, Basel, 2005 at 'http://www.karger.com.gate2.inist.fr/Article/FullText/85718'.
28. Rakyan VK, Down TA, Balding DJ, Beck S. Epigenome-wide association studies for common human diseases. Nat Rev Genet 2011; 12: 529-541.
29. Murrell A, Rakyan VK, Beck S. From genome to epigenome. Hum Mol Genet 2005; 14 Spec No 1: R3-R10.
30. Mill J, Heijmans BT. From promises to practical strategies in epigenetic epidemiology. Nat Rev Genet 2013; 14: 585-594.
31. Daughaday WH, Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 1989; 10: 68-91.
32. Rotwein P, Pollock KM, Didier DK, Krivi GG. Organization and sequence of the human insulin-like growth factor I gene. Alternative RNA processing produces two insulin-like growth factor I precursor peptides. J Biol Chem 1986; 261: 4828-4832.
33. Rotwein P. Structure, evolution, expression and regulation of insulin-like growth factors I and II. Growth Factors 1991; 5: 3-18.
34. Hall LJ, Kajimoto Y, Bichell D, Kim SW, James PL, Counts D et al. Functional analysis of the rat insulin-like growth factor I gene and identification of an IGF-I gene promoter. DNA Cell Biol 1992; 11: 301-313.
35. Eleswarapu S, Gu Z, Jiang H. Growth hormone regulation of insulin-like growth factor-I gene expression may be mediated by multiple distal signal transducer and activator of transcription 5 binding sites. Endocrinology 2008; 149: 2230-2240.
36. Chia DJ, Rotwein P. Defining the epigenetic actions of growth hormone: acute chromatin changes accompany GH-activated gene transcription. Mol Endocrinol 2010; 24: 2038-2049.